Separate real value from experimentation theater
The first move is diagnostic: identify which GenAI activity is genuinely tied to business friction and which activity only looks impressive without changing decision quality or delivery.
Make provider and workflow choices on operating criteria
Model choice is not a branding question. It changes governance, openness, latency, deployment shape, multimodality, and how far agentic workflows can responsibly go.
Build the operating model before scale creates debt
The briefing closes on leadership choices: who owns the agenda, how human oversight works, how pilots become standards, and what must be aligned before scale is credible.
When to use this brief
The right moment is when AI activity is real, but the decision frame is still weak.
- Your teams already have GenAI activity in motion, but leadership still lacks a coherent view of what should scale.
- Provider choices are being made too tactically, without enough attention to governance, openness, and deployment logic.
- There is pressure to show momentum, but adoption, oversight, and operating ownership are not yet clear.
- You need a sharper executive conversation before major investment, vendor selection, or organizational rollout.
What leaders leave with
- A clearer way to prioritize GenAI work by operating value rather than by novelty.
- A better frame for deciding where agentic workflows are appropriate and where simpler systems are enough.
- A more explicit view of governance, human oversight, and what an operating model has to include.
Related proof
This briefing pairs well with the Airbus case-study perspective because both are built on the same logic: clarify the real friction first, then sequence the right move so technology and adoption stay credible.
Read the Airbus case study →